Orr Patrick J 4
4 · HEALTHCARE SERVICES GROUP INC · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Healthcare Services Group (HCSG) EVP Patrick Orr Exercises Options, Sells Shares
What Happened
- Patrick J. Orr, EVP & Chief Revenue Officer of Healthcare Services Group (HCSG), exercised multiple option grants and sold the resulting shares on Feb 18, 2026. He acquired 45,500 shares by exercising four option tranches (total exercise cost ≈ $665,346) and sold 45,500 shares in an open-market transaction for $934,570. The filing also records corresponding derivative dispositions at $0, reflecting conversion of the options into shares.
Key Details
- Transaction date: 2026-02-18; filing date: 2026-02-19 (appears timely).
- Option exercises (acquisitions):
- 21,075 shares @ $18.10 = $381,458
- 7,016 shares @ $13.72 = $96,260
- 12,216 shares @ $10.36 = $126,558
- 5,193 shares @ $11.76 = $61,070
- Total exercise cost ≈ $665,346
- Open-market sale: 45,500 shares @ $20.54 = $934,570.
- Net cash difference (sale proceeds minus exercise cost) ≈ $269,224 (before taxes/fees).
- Shares owned after transaction: not specified in the filing.
- Footnotes (vesting): Options vest 20% annually (F1–F4) starting on grant anniversaries (Jan 4, 2022; Feb 24, 2023; Jan 3, 2024; Jan 3, 2025).
- No 10b5-1 plan or tax-withholding specifics disclosed in the Form 4.
Context
- The filing uses code "M" (option exercise). The matching sale of 45,500 shares the same day — plus $0 disposals of the derivative positions — is consistent with immediate sale of exercised shares (a cashless or immediate disposition pattern). This type of transaction documents conversion of options to shares and an immediate open-market sale; it is factual reporting of trades, not an indication of the insider’s motives.
Insider Transaction Report
Form 4
Orr Patrick J
EVP & Chief Revenue Officer
Transactions
- Exercise/Conversion
Common Stock
2026-02-18$18.10/sh+21,075$381,458→ 65,690 total - Exercise/Conversion
Common Stock
2026-02-18$13.72/sh+7,016$96,260→ 72,706 total - Exercise/Conversion
Common Stock
2026-02-18$10.36/sh+12,216$126,558→ 84,922 total - Exercise/Conversion
Common Stock
2026-02-18$11.76/sh+5,193$61,070→ 90,115 total - Sale
Common Stock
2026-02-18$20.54/sh−45,500$934,570→ 44,615 total - Exercise/Conversion
Stock Option (right to buy)
[F1]2026-02-18−21,075→ 5,268 totalExercise: $18.10Exp: 2032-01-04→ Common Stock (21,075 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F2]2026-02-18−7,016→ 10,524 totalExercise: $13.72Exp: 2033-02-24→ Common Stock (7,016 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F3]2026-02-18−12,216→ 18,322 totalExercise: $10.36Exp: 2034-01-03→ Common Stock (12,216 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F4]2026-02-18−5,193→ 20,772 totalExercise: $11.76Exp: 2035-01-03→ Common Stock (5,193 underlying)
Footnotes (4)
- [F1]These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2022 grant date.
- [F2]These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the February 24, 2023 grant date.
- [F3]These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2024 grant date.
- [F4]These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2025 grant date.
Signature
Michael Harrity, by Power of Attorney|2026-02-19